Page last updated: 2024-10-28

lidocaine and Malignant Carcinoid Syndrome

lidocaine has been researched along with Malignant Carcinoid Syndrome in 1 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Malignant Carcinoid Syndrome: A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. (Dorland, 27th ed; Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jabbour-Khoury, S1
Dabbous, A1
al-Jazzar, M1
Rizk, M1
Chahine, M1
Khalife, M1
Ayoub, C1
Baraka, A1

Other Studies

1 other study available for lidocaine and Malignant Carcinoid Syndrome

ArticleYear
Anesthetic management of a patient having a carcinoid syndrome.
    Middle East journal of anaesthesiology, 2003, Volume: 17, Issue:3

    Topics: Anesthesia, General; Anesthetics, Intravenous; Anesthetics, Local; Atracurium; Carcinoid Tumor; Fema

2003